Govt raises ceiling prices of BCG, Measles vaccines by 21%
The Indian government has increased the ceiling prices for BCG, Measles, and Measles-Rubella vaccines by 21%. This decision follows a review request from the Serum Institute of India regarding manufacturing costs and market dynamics.
Why it matters
Adjusting vaccine pricing impacts public health accessibility and the financial viability of critical pharmaceutical manufacturing in India.
Govt raises ceiling prices of BCG, Measles vaccines by 21% | India News - The Times of India
The article reports on a government regulatory decision and the manufacturer's response neutrally.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in